MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic NeoplasmsUta Oelschlaegel, Malte von Bonin, Frank Kroschinsky et al.|Leukemia|2024Cited by 7
P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY MULTIPARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIONMaximilian Roehnert, Uta Oelschlaegel, Michael Krämer et al.|HemaSphere|2023Cited by 0
PB1767: CHALLENGES IN MACHINE LEARNING-BASED DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIALars Thielecke, Ingmar Glauche, Friedemann Uschner et al.|HemaSphere|2023Cited by 0
HLA-DR Expression on Leukemic Progenitor Cells before Allogeneic Hematopoietic Cell Transplantation Adds Prognostic Value in the Presence of MRDMaximilian Alexander Röhnert, Carsten Müller‐Tidow, Jonas Schadt et al.|Blood|2024Cited by 0
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMMLUta Oelschlaegel, Maximilian Alexander Röhnert, Jonas Schadt et al.|HemaSphere|2025Cited by 0